Peroneal Nerve Dysfunction in Epiphyseal Transfer
1 other identifier
observational
15
1 country
1
Brief Summary
Assessment of peroneal nerve dysfunction after proximal fibular epiphyseal resection and evaluation of clinical outcome and EMG changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2023
CompletedFirst Posted
Study publicly available on registry
June 1, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFebruary 6, 2024
February 1, 2024
1.2 years
April 23, 2023
February 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of Tibialis anterior dysfunction after proximal fibular epiphyseal harvesting
Electromyography changes at 3 weeks , 6 weeks , 3 months and 6 months to assess the affection of tibialis anterior muscle \& peroneal nerve
Six months
Interventions
Measure the electrical activity of the muscle and nerve
Eligibility Criteria
Children with destroyed epiphysis whatever the cause of destruction and with preserved proximal fibular epiphysis
You may qualify if:
- all patients candidate for epiphyseal transfer are included ( patients with traumatic bone defect, congenital malformations, malignant bone lesions and infection )
You may not qualify if:
- patients in which there's no injury of nerve supply of tibialis anterior has occurred intraoperative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Omar
Asyut, 71511, Egypt
Related Publications (6)
Zelenski N, Brigman BE, Levin LS, Erdmann D, Eward WC. The vascularized fibular graft in the pediatric upper extremity: a durable, biological solution to large oncologic defects. Sarcoma. 2013;2013:321201. doi: 10.1155/2013/321201. Epub 2013 Oct 7.
PMID: 24222724BACKGROUNDShammas RL, Avashia YJ, Farjat AE, Catanzano AA, Levin LS, Eward WC, Brigman BE, Erdmann D. Vascularized Fibula-Based Physis Transfer: A Follow-Up Study of Longitudinal Bone Growth and Complications. Plast Reconstr Surg Glob Open. 2017 May 25;5(5):e1352. doi: 10.1097/GOX.0000000000001352. eCollection 2017 May.
PMID: 28607872BACKGROUNDGhert M, Colterjohn N, Manfrini M. The use of free vascularized fibular grafts in skeletal reconstruction for bone tumors in children. J Am Acad Orthop Surg. 2007 Oct;15(10):577-87. doi: 10.5435/00124635-200710000-00001.
PMID: 17916780BACKGROUNDInnocenti M, Delcroix L, Romano GF. Epiphyseal transplant: harvesting technique of the proximal fibula based on the anterior tibial artery. Microsurgery. 2005;25(4):284-92. doi: 10.1002/micr.20130.
PMID: 15934045BACKGROUNDSales de Gauzy J, Accadbled F, Gomez Brouchet A, Abid A. Case report: histologic study of a human epiphyseal transplant at 3 years after implantation. Clin Orthop Relat Res. 2009 Jul;467(7):1915-20. doi: 10.1007/s11999-009-0723-z. Epub 2009 Feb 11.
PMID: 19212796BACKGROUNDGrimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol. 2005 Feb;6(2):85-92. doi: 10.1016/S1470-2045(05)01734-1.
PMID: 15683817BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 23, 2023
First Posted
June 1, 2023
Study Start
June 1, 2023
Primary Completion
August 1, 2024
Study Completion
September 1, 2024
Last Updated
February 6, 2024
Record last verified: 2024-02